Guest guest Posted January 16, 2009 Report Share Posted January 16, 2009 The following information is put here for you to learn from. I personally have been warned by reputable people that all new drugs that hit the market are still IN TRIAL STAGE.... AND WE, THE UNSUSPECTING PUBLIC ARE USED AS THEIR UNWITTING TRIAL PARTICIPANTS. (Stage 4) Note in this brief announcement the comment: 1460 participants on active treatment ( that is a three month trial!) about 1/4 of the patients were classified as responders...... errrrr excuse me the other 3/4's???? what were the side effects? what are the long term outcomes of using this medication??? come on guy's...... give us some solid facts before you begin pushing even more dangerous drugs on us...... we are your guinea pigs in this remember! Clare in Tasmania NEW YORK, Jan. 15 -- The FDA has approved the selective serotonin and norepinephrine dual reuptake inhibitor milnacipran (Savella) for fibromyalgia, the drug makers announced.The approval was made on the basis of two phase III trials of 2,084 patients with fibromyalgia (1,460 on active treatment and 624 on placebo). They showed that doses of 100 mg/day and 200 mg/day caused significant improvement in a composite of pain, patient global assessment, and physical function.In a three-month trial, about a quarter of the patients on active treatment were classified as responders on the basis of the primary endpoint, but that was significantly higher than the 13.4% of placebo patients who responded. (See: ACR: Investigational Agent Shows Edge Over Placebo in Reducing Fibromyalgia Pain)Forest Laboratories and Cypress Bioscience, which own the North American rights to milnacipran, expect the drug to be available by March. It is sold outside the U.S. as an antidepressant by Pierre Fabre Laboratories in France. More. http://chronicdiseasenews.blogspot.com:80/2009/01/fda-okays-milnacipran-for-fibromyalgia.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.